To test this possibility, we evaluated the dynamic distributions of CD4+ T cell subsets based on their proportions and relative cell numbers per tumor size at different stages of cancer development in these two breast cancer models (Supplemental Figure 2A and 2B). This evidence concerns the gene CD4 and breast cancer.